mitoxantrone has been researched along with Leukemia, Lymphocytic, T Cell in 8 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Y | 1 |
| Tang, P | 1 |
| He, X | 1 |
| Xie, Y | 1 |
| Cheng, W | 1 |
| Xing, X | 1 |
| Xing, M | 1 |
| Lu, X | 1 |
| Liu, S | 1 |
| Zhong, L | 1 |
| White, Y | 1 |
| Hamada, T | 1 |
| Yoshimitsu, M | 1 |
| Nakashima, M | 1 |
| Hachiman, M | 1 |
| Kozako, T | 1 |
| Matsushita, K | 1 |
| Uozumi, K | 1 |
| Suzuki, S | 1 |
| Kofune, H | 1 |
| Furukawa, T | 1 |
| Arima, N | 1 |
| Au, WY | 2 |
| Lam, CC | 2 |
| Chim, CS | 1 |
| Pang, AW | 1 |
| Kwong, YL | 2 |
| Valiev, TT | 1 |
| Vinogradova, IuE | 1 |
| Chernova, NG | 1 |
| Mar'in, DS | 1 |
| Volkova, IaK | 1 |
| Petrova, VI | 1 |
| Bulanov, AIu | 1 |
| Kalinin, NN | 1 |
| Semenova, EA | 1 |
| Gretsov, EM | 1 |
| Kravchenko, SK | 1 |
| Kremenetskaia, AM | 1 |
| Vorob'ev, AI | 1 |
| Tse, E | 1 |
| Chan, JC | 1 |
| Pang, A | 1 |
| Leung, AY | 1 |
| Landowski, TH | 1 |
| Gleason-Guzman, MC | 1 |
| Dalton, WS | 1 |
| Styczynski, J | 1 |
| Pieters, R | 1 |
| Huismans, DR | 1 |
| Schuurhuis, GJ | 1 |
| Wysocki, M | 1 |
| Veerman, AJ | 1 |
| Nishizaki, H | 1 |
| Sumida, M | 1 |
8 other studies available for mitoxantrone and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Study on the precise mechanism of Mitoxantrone-induced Jurkat cell apoptosis using surface enhanced Raman scattering.
Topics: Antineoplastic Agents; Apoptosis; DNA; Humans; Intercalating Agents; Jurkat Cells; Leukemia, T-Cell; | 2020 |
Novel cytotoxic isolated from Jamaican Hyptis verticillata jacq induces apoptosis and overcomes multidrug resistance.
Topics: Antineoplastic Agents; Apoptosis; Cytotoxins; Dioxolanes; DNA Damage; Drug Resistance, Multiple; Dru | 2011 |
Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; | 2005 |
[Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Prolymphocytic; | 2006 |
Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Humans; Leukemia | 2007 |
Selection for drug resistance results in resistance to Fas-mediated apoptosis.
Topics: Antibodies, Monoclonal; Apoptosis; Cross-Linking Reagents; Doxorubicin; Drug Resistance, Neoplasm; f | 1997 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child | 2000 |
[A case of chronic adult T-cell leukemia benefited by small doses of MEPP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cisplatin; Drug Administration Sche | 1988 |